Hanif Malik Muhammad, Akram Khizra, Mustafa Ghulam
Department of Dermatology, Sheikh Zayed Medical College/Hospital, Rahim Yar Khan.
Department of Community Medicine, Sheikh Zayed Medical College/Hospital, Rahim Yar Khan.
J Coll Physicians Surg Pak. 2016 Apr;26(4):260-2.
To compare intralesional versus oral chloroquine in cutaneous leishmaniasis and determine the cure rate, duration of treatment, and total dose of drug.
Randomized controlled study.
Department of Dermatology, Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, from November 2013 to June 2014.
Consecutive 86 patients of cutaneous leishmaniasis, with single to multiple lesions of various sizes were enrolled and divided randomly into group Aand B for the purpose of intralesional and oral chloroquine administration, respectively to compare the effect of the two routes on duration of treatment and total dose of the drug. SPSS version 16 was used for data analysis after data entry into it. Quantitative variables like, duration, cost and total dose of treatment were calculated as mean and standard deviation and compared by using T-test. P-value of less than 0.05 was taken as significant.
Cure rate was 100% in both groups towards the end of treatment. Mean duration of treatment was 9.17 ±3 weeks in intralesional (A) group as against 11.37 ±3 weeks in oral (B) group (p = 0.0028). Mean total dose of the drug given to each patient in group Awas 5.8 ±0.5 gm and in group B, it was 19.2 ±1.5 gm, which is significantly higher (p < 0.001). The total cost of treatment in group Awas Rs. 90 ±8 and in group B it was Rs. 91 ±1 (p=0.446).
Duration of treatment is significantly shorter and total dose is lesser with intralesional compared to oral chloroquine in treatment of cutaneous leishmaniasis.
比较皮损内注射与口服氯喹治疗皮肤利什曼病的效果,并确定治愈率、治疗持续时间和药物总剂量。
随机对照研究。
2013年11月至2014年6月,拉希姆亚尔汗市谢赫扎耶德医学院/医院皮肤科。
连续纳入86例皮肤利什曼病患者,这些患者有单个或多个大小各异的皮损,随机分为A组和B组,分别接受皮损内注射和口服氯喹治疗,以比较两种给药途径对治疗持续时间和药物总剂量的影响。数据录入SPSS 16版后进行数据分析。治疗持续时间、费用和总剂量等定量变量以均值和标准差计算,并采用t检验进行比较。P值小于0.05被视为具有显著性。
治疗结束时两组治愈率均为100%。皮损内注射(A)组的平均治疗持续时间为9.17±3周,口服(B)组为11.37±3周(p = 0.0028)。A组每位患者的药物平均总剂量为5.8±0.5克,B组为19.2±1.5克,A组显著更低(p < 0.001)。A组的总治疗费用为90±8卢比,B组为91±1卢比(p = 0.446)。
在治疗皮肤利什曼病时,与口服氯喹相比,皮损内注射氯喹的治疗持续时间显著更短,药物总剂量更少。